Related Experiment Videos

Clearance from cerebrospinal fluid of intrathecally administered beta-endorphin in monkeys

Insights

This study found that beta-endorphin, a natural painkiller, is cleared from cerebrospinal fluid similarly to inulin. This suggests beta-endorphin elimination occurs via bulk absorption in the spinal fluid.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Physiology

Background:

  • Beta-endorphin is a key endogenous opioid peptide involved in pain modulation.
  • Understanding the elimination kinetics of beta-endorphin from cerebrospinal fluid (CSF) is crucial for its therapeutic applications.

Purpose of the Study:

  • To investigate the elimination rate and mechanism of synthetic human beta-endorphin from the CSF in non-human primates.
  • To compare the clearance of beta-endorphin with that of inulin, a substance cleared solely by bulk absorption.

Main Methods:

  • Intrathecal administration of synthetic human beta-endorphin and [14C]methoxy-inulin into adult male rhesus monkeys.
  • Serial sampling of CSF via an indwelling spinal catheter.
  • Assay of beta-endorphin concentrations using radioimmunoassay and inulin using liquid scintillation counting.

Main Results:

  • CSF concentrations of both beta-endorphin and inulin exhibited parallel peak and decline patterns.
  • The clearance ratio between beta-endorphin and inulin was consistently near unity across all subjects (mean value of 1.060 +/- 0.090).

Conclusions:

  • Beta-endorphin appears to be eliminated from the CSF through a process similar to bulk absorption, analogous to inulin clearance.
  • These findings support the understanding of opioid peptide pharmacokinetics within the central nervous system.

Related Concept Videos